U.S. Tech Hardware Stock News

NasdaqGS:PENN
NasdaqGS:PENNHospitality

A Look At PENN Entertainment (PENN) Valuation As Expansion Projects And New Financing Move Ahead

Expansion plans and fresh financing reshape the PENN Entertainment story PENN Entertainment (PENN) has put expansion and balance sheet moves front and center, with new casino and hotel projects in Aurora and Columbus alongside a fresh US$600 million senior notes offering. See our latest analysis for PENN Entertainment. Despite the new projects and financing, PENN’s 1 year total shareholder return of 21.21% and 5 year total shareholder return of 86.08% sit well behind peers. A recent 4.99% 1...
NasdaqGM:RYTM
NasdaqGM:RYTMBiotechs

Assessing Rhythm Pharmaceuticals (RYTM) Valuation After FDA Approval Expands IMCIVREE’s Obesity Indication

Rhythm Pharmaceuticals (RYTM) is back in focus after the FDA approved a broader label for IMCIVREE to treat acquired hypothalamic obesity in patients aged 4 and up, supported by Phase 3 TRANSCEND data. See our latest analysis for Rhythm Pharmaceuticals. Despite the FDA approval and new PANTHERx distribution agreement, Rhythm Pharmaceuticals’ recent share price performance has softened. The 30 day share price return shows a decline of 12.36% and the 90 day share price return shows a decline of...
NasdaqGS:CTAS
NasdaqGS:CTASCommercial Services

A Look At Cintas (CTAS) Valuation After Midland MVPP Star Safety Recognition

Safety recognition puts Cintas (CTAS) in focus The recent MVPP Star Worksite certification for Cintas (CTAS) in Midland, Michigan, from the state safety regulator is drawing attention to how workplace safety practices might fit into the broader investment case. See our latest analysis for Cintas. The MVPP Star recognition comes at a time when Cintas shares, last closing at $179.34, have faced a 10.34% 1 month share price decline and a 3% year to date share price decline. Over the last 5...
NYSE:KSS
NYSE:KSSMultiline Retail

A Look At Kohl's (KSS) Valuation As Profitability Improves And Store Efficiency Becomes The Focus

Kohl's earnings update and guidance reset investor focus Kohl's (KSS) recent quarter and full year results, paired with 2026 guidance and comments on store operations, give you fresh context for assessing the stock after a sharp pullback in recent months. See our latest analysis for Kohl's. The 1 year total shareholder return of 37.11% contrasts sharply with the recent 30 day share price return of negative 33.81% and year to date share price return of negative 41.75%. This suggests momentum...
NYSE:PLNT
NYSE:PLNTHospitality

A Look At Planet Fitness (PLNT) Valuation After Recent Board And Interim CFO Changes

Planet Fitness (PLNT) has drawn fresh attention after a board reshuffle and finance leadership change, bringing in Levi Strauss executive Harmit Singh as director and reinstating seasoned company veteran Tom Fitzgerald as Interim CFO. See our latest analysis for Planet Fitness. At a share price of US$74.34, Planet Fitness has seen a 30 day share price return of 18% decline and a 90 day share price return of 33% decline, contributing to a 1 year total shareholder return of 27% loss. This...
NasdaqGM:ADMA
NasdaqGM:ADMABiotechs

Assessing ADMA Biologics (ADMA) Valuation After Fresh Analyst Upgrades And Strong Buy Sentiment

Analyst sentiment around ADMA Biologics (ADMA) has turned more positive, with a consensus Strong Buy rating and upward revisions to earnings estimates. This has drawn fresh attention to the stock and its recent share price performance. See our latest analysis for ADMA Biologics. Despite the recent analyst optimism, ADMA Biologics' 1 day share price return of a 4.66% decline and 7 day share price return of a 9.6% decline add to a year to date share price return of a 19.91% decline. However,...
NYSE:KRP
NYSE:KRPOil and Gas

The Bull Case For Kimbell Royalty Partners (KRP) Could Change Following New US$100M Buyback Plan

Kimbell Royalty Partners, LP recently announced a unit repurchase program authorizing up to US$100 million of buybacks funded by cash, free cash flow, or borrowings under its revolving credit facility, with authorization running through December 31, 2027. This sizeable and time-limited repurchase plan highlights management’s capital allocation priorities and could influence expectations for future distributions and growth investments. We’ll now examine how this new US$100 million repurchase...
NYSE:SLG
NYSE:SLGOffice REITs

Assessing SL Green (SLG) Valuation After Its US$2.0b Credit Facility Refinancing

Why SL Green’s New Credit Facility Matters For Shareholders SL Green Realty (SLG) has just refinanced and extended US$2.0b of its US$2.4b corporate credit facility, cutting borrowing costs and pushing key maturities out to 2031, which represents a material shift in its financing profile. See our latest analysis for SL Green Realty. The refinancing news lands after a mixed period for investors, with a 1 day share price return of 5.47% decline, a 90 day share price return of 15.68% decline, and...
NYSE:ESTC
NYSE:ESTCSoftware

Assessing Elastic (ESTC) Valuation After Recent Share Price Weakness

Why Elastic is on investors’ radar today Elastic (ESTC) has caught investor attention after recent share price weakness, with the stock down over the past month and past 3 months, prompting fresh questions about how its Search AI Platform business fits into current market expectations. See our latest analysis for Elastic. Those recent share price declines sit within a tougher stretch overall, with a 30 day share price return of an 8.28% decline and a 1 year total shareholder return of a...
NasdaqGS:AMD
NasdaqGS:AMDSemiconductor

Upstage Talks Put AMD MI355 In Focus For Asian AI Growth

South Korean AI startup Upstage is in advanced talks with AMD (NasdaqGS:AMD) to purchase 10,000 MI355 AI accelerators. The potential deal would expand AMD’s presence in the Korean and broader Asian AI chip market. Upstage is seeking to diversify its supply chain away from Nvidia for major AI projects in South Korea. For investors following NasdaqGS:AMD, this potential order highlights how AI infrastructure demand is spreading across regions and vendors. AMD already competes in CPUs, GPUs,...
NYSE:ARE
NYSE:AREHealth Care REITs

Does Removal From FTSE All-World Index Change The Bull Case For Alexandria Real Estate Equities (ARE)?

Alexandria Real Estate Equities, Inc. was removed from the FTSE All-World Index (USD) on 21 March 2026, altering its status within a major global benchmark tracked by many institutional investors. This index deletion could influence trading activity and liquidity for Alexandria Real Estate Equities as index-tracking funds and related mandates reassess their positions. We’ll now examine how Alexandria’s removal from the FTSE All-World Index may affect its investment narrative and longer-term...
NasdaqGS:CCC
NasdaqGS:CCCSoftware

Does CCC (CCC) Embedding VSSTA Into CCC ONE Hint At A Stickier Platform Strategy?

On March 17, 2026, CCC Intelligent Solutions Inc. announced that remote diagnostics provider VSSTA joined the CCC Diagnostics Network, allowing collision repairers to automatically receive VSSTA scan and calibration reports and related invoices directly within the CCC ONE workfile at no additional integration cost. This deeper integration of ADAS-related diagnostics into CCC ONE highlights how CCC is embedding itself further into repair shop workflows, tightening links between repairers and...
NasdaqGS:ENVX
NasdaqGS:ENVXElectrical

Manufacturing And Margin Pressures Might Change The Case For Investing In Enovix (ENVX)

In recent commentary, Bank of America analyst Ruplu Bhattacharya highlighted Enovix as a leader in next-generation high-energy-density lithium-ion batteries, while the company cautioned that manufacturing hurdles, long qualification cycles, and expected negative margins and cash flow could constrain its near-term potential. This mix of technological promise and operational strain underscores how Enovix’s path to commercialization may be lengthy and costly, even if its battery architecture...
NasdaqGM:WINA
NasdaqGM:WINASpecialty Retail

Assessing Winmark (WINA) Valuation After A Recent Share Price Pullback

Why Winmark’s recent share performance is drawing attention Winmark (WINA) has caught investor attention after a recent share price slide, with a 13% decline over the past month and a 2% decline over the past 3 months, despite a 26% total return over the past year. See our latest analysis for Winmark. Recent share price returns suggest momentum has faded in the short term, with the recent slide contrasting with a much stronger 1 year total shareholder return that still reflects earlier gains...
NasdaqCM:LIDR
NasdaqCM:LIDRElectronic

Assessing AEye (LIDR) Valuation After NVIDIA Halos Partnership And Mixed 2025 Earnings

AEye (LIDR) has just joined the NVIDIA Halos AI Systems Inspection Lab while also releasing fourth quarter and full year 2025 results, a combination that puts both its technology partnerships and financial profile in focus. See our latest analysis for AEye. The share price has been volatile around these announcements, with a 7 day share price return of 44.52% and a 1 day decline of 13.51%. Over 1 year, the total shareholder return is very large compared to the longer term 3 year and 5 year...
NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

Assessing Whether Henry Schein (HSIC) Shares Look Undervalued After Recent Weak Momentum

Recent share performance and business snapshot Henry Schein (HSIC) has drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, and past 3 months, despite a modest positive 1 year total return. The company provides a broad range of health care products and services, with revenue of US$13.2b and net income of US$398.0m, primarily through its Global Distribution and Value Added Services segment. See our latest...
NasdaqCM:CPRX
NasdaqCM:CPRXBiotechs

Is Catalyst Pharmaceuticals (CPRX) Pricing Look Interesting After Recent Share Price Pullback?

If you are wondering whether Catalyst Pharmaceuticals at around US$22.79 is priced high, low, or just about fair, this article breaks down what the current tag might really mean for you. The stock has seen mixed returns, with a 2.2% decline over the last week, a 6.2% decline over the last month, a 1.6% decline year to date, but a 38.6% gain over 3 years and a very large gain over 5 years. Recent coverage has focused on how this biopharma name fits into investors’ watchlists, with attention...
NasdaqGS:VNET
NasdaqGS:VNETIT

VNET Group (VNET) Is Down 7.5% After Mixed 2025 Results and 2026 Revenue Guidance Update

VNET Group, Inc. recently reported its fourth-quarter and full-year 2025 results, showing quarterly revenue rising to CNY 2,687.09 million and a swing to CNY 304.67 million in net income, while providing 2026 full-year revenue guidance of RMB 11.5 billion to RMB 11.8 billion and announcing the resignation of director Jianbiao Zhu on March 9, 2026. An interesting takeaway is that despite generating CNY 9,949.26 million in 2025 sales and returning to profitability in the latest quarter, VNET...
NYSE:W
NYSE:WSpecialty Retail

A Look At Wayfair (W) Valuation After Recent Share Price Weakness And Intrinsic Value Gap

Wayfair stock reaction and recent performance snapshot Wayfair (W) shares have been under pressure recently, with the stock showing a 5.1% decline over the past day and an 8.5% drop over the past week, prompting closer attention from investors. Over the past month the stock is down 11.2%, and over the past 3 months it has declined 28.8%, while the most recent close sits at US$72.35 and the company’s market value is about US$9.46b. See our latest analysis for Wayfair. Despite the recent...
NYSE:COLD
NYSE:COLDIndustrial REITs

Assessing Americold Realty Trust’s Valuation After A Steep 1 Year Shareholder Return Decline

Recent share performance and business snapshot Americold Realty Trust (COLD) has seen its share price come under pressure, with a last close of US$11.25. Negative total returns over the past year and the past 3 months have drawn investor attention. The company operates 231 temperature controlled facilities across multiple regions. It generates US$2,599.734 in revenue, primarily from warehouse services, transportation, and third party managed operations in North America, Europe, Asia Pacific,...
NYSE:MMS
NYSE:MMSProfessional Services

Assessing Maximus (MMS) Valuation As Shareholder Returns Lag Recent Revenue And Earnings Growth

Why Maximus Stock Is Back on Investors’ Radar Maximus (MMS) has drawn attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, and year to date. At the same time, the company reports annual revenue of US$5.37b and net income of US$371.78m, supported by modest annual growth in both metrics. This gives investors concrete figures to assess against recent price moves. See our latest analysis for Maximus. Despite a...
NYSE:AR
NYSE:AROil and Gas

Assessing Antero Resources (AR) Valuation After Recent Share Price Momentum

Recent performance snapshot Antero Resources (AR) has drawn fresh attention after a recent move in its share price, with the stock returning 21.24% over the past month and 28.17% over the past 3 months. See our latest analysis for Antero Resources. The recent 21.24% 1 month share price return, alongside a 28.17% 3 month gain and a 25.96% year to date move at a US$43.09 share price, comes on top of a 5.69% 1 year total shareholder return and a much stronger 3 year total shareholder return of...
NYSE:CTRE
NYSE:CTREHealth Care REITs

Is It Too Late To Consider CareTrust REIT (CTRE) After Recent Pullback?

Assessing whether CareTrust REIT is priced attractively today, or if the easy gains are already behind it, starts with a clear look at what the current share price implies about its value. The stock closed at US$36.10, with returns of 29.8% over 1 year and very large gains over 3 and 5 years, while the last 7 and 30 days show declines of 10.0% and 9.9% and the year to date move is a modest 0.6% decline. Recent market attention has focused on CareTrust REIT as a health care focused real...
NYSE:PNR
NYSE:PNRMachinery

Is Pentair (PNR) Offering Opportunity After Recent 15% Share Price Pullback?

This article examines whether Pentair, trading at around US$86.49, is offering fair value or a mispriced opportunity by breaking down what the current share price might be implying about the company. Over the past month the stock has recorded a 15.2% decline and an 18.0% decline year to date, while the 3 year and 5 year returns of 69.8% and 48.2% provide a longer term contrast to the recent 2.6% 7 day move and 2.8% 1 year decline. Recent market attention on Pentair has been shaped by ongoing...